Physician profile
Andrew Moritz
NPI 1265640809
$2,005.09
in general payments reported to CMS, 2019-2025
21 companies · $335 in 2025
The $335 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $464 · 2020: $350 · 2021: $283 · 2022: $406 · 2023: $53.07 · 2024: $114 · 2025: $335.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $503.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $502.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $461.46 | 2020-2025 | Blueprint Patient Specific Instrumentation, Mako, Gamma |
| Smith+Nephew, INC. | $241.25 | 2019-2025 | Allevyn Heel 10.5cm X 13.5cm Ctn 5, Collagenase Santyl |
| Depuy Synthes Sales INC. | $238.05 | 2020-2023 | Fibergraft Bg Morsels |
| Horizon Therapeutics Plc | $204.60 | 2019-2021 | |
| Vericel Corporation | $160.46 | 2020-2022 | |
| Wright Medical Technology, INC. | $152.78 | 2019 | |
| Pacira Therapeutics, INC. | $144.50 | 2019-2021 | |
| Si-Bone, INC. | $99.64 | 2022 | |
| Bioventus LLC | $45.94 | 2024-2025 | Durolane, Exogen Ultrasound Bone Healing System |
| Axogen | $35.68 | 2024-2025 | Axoguard Nerve Cap, Axoguard Ha+ Nerve Protector, Axoguard Nerve Protector |
| Vertex Pharmaceuticals Incorporated | $33.63 | 2024-2025 | |
| Innovation Technologies INC | $24.34 | 2024 | Irrisept |
| Averitas Pharma INC. | $22.98 | 2023 | Qutenza |
| Pacira Pharmaceuticals Incorporated | $22.63 | 2022 | |
| Sanofi-Aventis U.S. LLC | $19.11 | 2019 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ferring Pharmaceuticals INC. | $18.81 | 2021 | |
| Kci USA, INC. | $18.61 | 2022 | |
| Organogenesis INC. | $16.04 | 2022 | |
| Djo, LLC | $15.53 | 2019 | |
| Medtronic, INC. | $14.63 | 2024 | Intellis Adaptivestim |
| Baudax Bio INC. | $14.42 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Moritz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.